The Nomination & Remuneration Committee (NRC) of the Board of Directors approved the allotment at its meeting held on Tuesday, July 14, 2026. The meeting commenced at 02:45 p.m. and concluded at 03:00 p.m.

Allotment Details:

  • 40,100 equity shares were allotted to option grantees who exercised their options under the Company's Employee Stock Option Plan 2023.
  • The equity shares allotted rank pari passu with the existing equity shares of the Company.

Capital Structure Impact:

  • Pre-allotment paid-up share capital: ₹31,51,31,500 consisting of 6,30,26,300 equity shares of ₹5 each
  • Post-allotment paid-up share capital: ₹31,53,32,000 consisting of 6,30,66,400 equity shares of ₹5 each
  • Increase in share capital: ₹2,00,500

Financial Details:

  • Money realized by exercise of options: ₹2,00,500
  • Exercise price per share: ₹5
  • Face value of shares: ₹5 each

ESOP Plan Terms:

  • The scheme is in compliance with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
  • Options were granted to employees with approval of the Nomination and Remuneration Committee.
  • Vested options can be exercised at any time from the respective date(s) of vesting till 120 months.
  • The equity shares allotted are subject to a lock-in period of 1 year.
  • No options lapsed, and no variations or cancellations of terms occurred.

Earnings Impact:

  • The diluted earnings per share for the quarter ended June 30, 2026, is ₹3.63 per share.

The disclosure is made in accordance with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. The information will be available on the company's website at https://anandrathi.com/investors.